Today's Date: February 8, 2023
THE ELLINIKON, ONE OF THE WORLD'S LARGEST URBAN REGENERATION PROJECTS, BREAKS GROUND ON RIVIERA TOWER, GREECE'S TALLEST BUILDING   •   Strateos Appoints Alexander K. Arrow as Chief Financial Officer and Expands Team   •   Demand for Breastfeeding Support Drives Growth of Nest Collaborative Telehealth Platform   •   CAROL'S DAUGHTER ANNOUNCES BORN TO REPAIR (& MADE TO CARE): BREAKTHROUGH RANGE OF PH BALANCING FORMULAS INSTANTLY HELPS REPA   •   KIA WINS 2023 VINCENTRIC BEST VALUE IN AMERICA AWARDS FOR 2023 SORENTO PHEV AND RIO   •   Navisite Announces Inaugural Winners of Steminist Scholarship Program in India Supporting Young Women in STEM   •   Pivot Point Consulting Named Best in KLAS: Managed IT Services   •   CGI's 2022 ESG Report details its progress in building a more sustainable and inclusive world for all   •   Orion Talent Partners with U.S. Department of Labor to Support Military Transitioning Service Members, Spouses   •   Lineage Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss   •   Center for Caregiver Advancement Addresses Urgent Need for Caregiver Training Through Career Pathways Program   •   Good News: Inflation and Unemployment Lower; Customer Satisfaction Up   •   Premier Litigation Finance Firm Rocade LLC Partners With Barings and EJF Capital   •   CSI’s Banking-as-a-Service Capabilities Facilitate New Fintech Partnerships   •   AmerisourceBergen Releases 2022 ESG Summary Report to Share Progress and Impact on Environmental, Social and Governance Prioriti   •   Edifecs Tops 2023 Best In KLAS for New CMS Payer Interoperability Category   •   NTT and the University of Tokyo Develop World’s First Optical Computing AI Using an Algorithm Inspired by the Human Brain   •   Swim Instruction Leader Aqua-Tots Launches New Swim School App   •   Guardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced   •   Kay Baltzell-Rathbone's newly released "Communing With Christ" is a thought-provoking collection of devotions that encourage ref
Bookmark and Share

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behal

LOS ANGELES , January 25 /Businesswire/ - Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) investors who purchased: (a) Class A common stock pursuant and or traceable to the Offering Documents issued in connection with the Company’s February 2021 initial public offering (“IPO”); and/or (b) securities between February 11, 2021 and November 21, 2022, inclusive (the “Class Period”). Bioventus investors have until March 13, 2023 to file a lead plaintiff motion.

If you suffered a loss on your Bioventus investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/bioventus-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On or about February 11, 2021, Bioventus conducted its IPO selling 8 million shares of Class A common stock at $13 per share.

On November 16, 2022, Bioventus issued a press release announcing that it could not timely file its quarterly report for the period ended October 1, 2022 because of “the recent decline in the Company's market capitalization subsequent to its previously announced financial results for the third quarter of 2022," which resulted in the Company needing "additional time . . . to assess whether a non-cash impairment charge is required for the third quarter of 2022." The Company also noted that it was "seeking resolution related to the validity of a revised invoice" regarding "rebate claims” which would likely adversely affect the Company's previously announced third quarter 2022 financial results." Moreover, the Company disclosed that "its internal controls related to the timely recognition of quarterly rebates were inadequate."

On this news, Bioventus's stock price fell $1.00 per share, or 33.67%, to close at $1.97 per share on November 17, 2022, representing a total decline of 84.85% from the IPO price.

Then, on November 21, 2022, Bioventus issued a press release announcing revised third quarter 2022 results to account for “additional rebate claims related to certain of the Company’s products and a non-cash impairment charge” that amounted to $189.2 million “due to the recent decline in […] market capitalization subsequent to [its] previously announced financial results.” Additionally, Bioventus advised of various changes to its historical practices that were necessary to account for rebates, stating that these changes materially impacted the Company’s evaluation of its ability to meet debt covenants, resulting in liquidity and going concern disclosures.

On this news, Bioventus’s stock price fell $0.07, or 3.72%, to close at $1.81 per share on November 22, 2022, thereby injuring investors further.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Bioventus suffered from significant liquidity issues; (2) the Company's rebate practices were unsustainable; (3) accordingly, Defendants overstated the Company's business and financial prospects; (4) Bioventus maintained deficient disclosure controls and procedures and internal control over financial reporting with respect to the timely recognition of quarterly rebates; (5) all the foregoing increased the risk that the Company would be forced to recognize a significant non-cash impairment charge, could not timely file one or more of its financial reports, would have to amend one or more of its financial statements, and could not meet its financial obligations as they came due; and (6) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Bioventus securities during the Class Period, you may move the Court no later than March 13, 2023 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


STORY TAGS: Lawsuit, United States, North America, Class Action Lawsuit, Professional Services, Legal, California,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News